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Lumber laminectomyAbstract Background: This study evaluated the efficacy of transdermal fentanyl (TDF) delivery
system (50 lg/h) or transdermal melatonin (TDM) delivery system (7 mg) 2 h preoperatively for
acute postoperative pain after lumbar laminectomy compared to placebo group (C).
Methods: Seventy-five patients of both sexes, aged 18–50 years, ASA I and II undergoing elective
single level lumber laminectomy under general anesthesia were included in this randomized con-
trolled double-blind study. Patients were randomly divided into 3 groups 25 each, C group patients
received transdermal placebo patch, TDF group (50 lg/h) and TDM group (7 mg). Assessment of
postoperative pain, sedation, hemodynamic variables such as HR and MAP, postoperative moni-
toring of arterial SpO2 and side effects (e.g. nausea, vomiting, pruritis, respiratory depression
and hemodynamic instability) was done 30 min, 1, 2, 6 and 12 h postoperatively. Postoperative
Patient‘s and Surgeons‘ satisfaction, Intraoperative bleeding and plasma cortisol (lg/dl) postoper-
atively were also assessed.
Results: There was a significant reduction in the VAS score, total pethidine requirements and sig-
nificantly higher Patient‘s satisfaction in TDF and TDM groups when compared with the C group
6 h postoperatively. The sedation score and Surgeons‘ satisfaction were significantly higher associ-
ated with a significant decrease in MAP and Intraoperative bleeding in TDM group compared to
groups C and TDF 6 h postoperatively. Significant nausea and vomiting in TDF group and signif-
icant sedation in TDM group were recorded.t., Saint
324 I.M. Esmat, D.Y. KassimConclusion: The use of preoperative TDF 50 lg/h or TDM 7 mg was an effective and a safe adju-
vant for acute pain after surgery.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
‘‘Freedom from pain should be a basic human right, limited
only by our knowledge to achieve it” [1]. Central sensitization
and hyperexcitability develop after the surgical incision result-
ing in amplification of postoperative pain [2]. Kissin intro-
duced the term ‘preventive analgesia’ to emphasize the fact
that central sensitization is induced by noxious preoperative
and postoperative inputs [3,4]. McCaffery and Ferrell showed
that over 50% of surgical patients experienced inadequate pain
relief following surgery with negative physiological and psy-
chological consequences [5]. Surgical injury elicits a well-
known stress response involving activation of inflammatory,
endocrine, metabolic and immunologic mediators [6]. Prevent-
ing the establishment of altered central processing by analgesic
treatment may result in short-term (e.g., reduction in postoper-
ative pain and accelerated recovery) and long-term (e.g., reduc-
tion in chronic pain and improvement in health related quality
of life) benefits during a patient’s convalescence [2]. These con-
cepts suggest a possible study design; effective analgesia starts
before incision and covers both the period of surgery and the
postoperative period.
Transdermal drug delivery offers the potential benefits of
simplicity, efficacy and patient acceptance. In theory, a trans-
dermal delivery system can provide a stable serum concentra-
tion for an extended period of time with acceptable
interpatients variability [7].
Fentanyl citrate is a potent synthetic narcotic with physico-
chemical characteristics that are suitable for rate controlled
transdermal delivery. These characteristics include high
potency, skin compatibility, low molecular weight, and appro-
priate solubility [8]. Transdermal delivery system for fentanyl
(TDF) has been developed and approved for the treatment
of cancer and chronic pain and it has been demonstrated that
transdermal fentanyl provides effective analgesia for acute
postoperative pain. TDF does not require I.V. access and the
risk of infection is decreased [9]. Fentanyl patches are designed
to deliver fentanyl at four constant rates: 25, 50, 75, and
100 lg/h for a period of 72 h. The steady-state serum concen-
tration is reached after 24 h and maintained as long as the
patch is renewed [10]. The choice of the transdermal delivery
system of fentanyl with a predicted delivery rate of 50 lg/h
was based on a previous study characterizing the relationship
between serum fentanyl concentrations and analgesic effects
in patients undergoing abdominal surgery. Some studies
demonstrated a non-significant reduction in opioid require-
ments using delivery rates of 25 lg/h [11–14]. On the other
hand, up to 9% of patients were at risk of respiratory depres-
sion when being treated with TDF 75 lg/h (administered 8 h
prior to surgery) [14]. For management of postoperative pain,
it may be desirable to apply transdermal fentanyl several hours
before completion of surgery so that minimal effective concen-
tration (MEC) can be achieved prior to or concomitant with
the end of surgery [15].Melatonin (N-acetyl-5-methoxytryptamine, MT) is a hor-
mone secreted primarily by the pineal gland in a circadian
fashion. The synthesis and secretion of MT is induced by dark-
ness and suppressed by light through retinal nerve fibers pro-
jecting to the suprachiasmatic nucleus of hypothalamus, then
to the superior cervical ganglion and finally to the pineal
gland. During the night, the mean endogenous plasma concen-
tration of MT is 50–70 pg/mL (216–302 pmol/L) in young
adults. In daylight hours, the mean MT plasma concentration
is typically <10 pg/mL (43 pmol/L). Plasma MT levels typi-
cally begin to increase at 2100 h, peak between 0200 and
0400 h, and return to baseline at 0700–0900 h [16]. MT has a
short plasma elimination half-life, 45 min, and, when admin-
istered orally, shows low and variable bioavailability, presum-
ably due to extensive first-pass metabolism and/or variable
absorption [17]. Transdermal delivery system for melatonin
(TDM) results in sustained plasma MT levels that can be tai-
lored to the normal physiological range and avoid the first-
pass metabolism. TDM is intended to be worn for 8 h [18].
Melatonin has sedative, anxiolytic, analgesic, antihypertensive,
anti-inflammatory, chronobiotic and oncostatic effects and
potent antioxidant properties [19]. Melatonin exerts its anal-
gesic effects through augmentation of GABA-ergic systems
and morphine anti-nociception, enhancing GABA-induced
currents and inhibiting glycine effects [20]. Melatonin may
enhance the levels of b-endorphins and the anti-nociception
induced by delta opioid receptor agonists and could activate
MT2 melatonin receptors in the dorsal horn of the spinal cord
[21,22].
Spine surgery may range from minimal invasive discectomy
surgery to extended scoliosis fusion. Both an anterior
approach and posterior approach are possible. The most com-
monly used technique to anesthetize patients scheduled for
thoracic or lumbar spine surgery is general anesthesia followed
by conventional pain therapy [23]. Controlling the hemody-
namic situation of patients who have spinal operation is of
prime importance and maintaining the heart rate and blood
pressure in normal or low-normal levels in these patients can
reduce bleeding in the surgical field, particularly in congested,
small and limited areas such as spine [24].
Surgical trauma elicits endocrine and metabolic changes
characterized by an increase in the secretion of catecholamines.
Pain and other afferent neurogenic stimuli from the site of the
operation are known to play a dominant role in this mecha-
nism [25,26]. The stress response to surgery is characterized
by increased secretion of pituitary hormones and activation
of the sympathetic nervous system. The changes in the pitu-
itary secretions have secondary effects on hormone secretion
from target organs (increased secretion of cortisol from the
adrenal cortex) [27].
In this randomized, double-blind, placebo-controlled study,
our primary goal was to compare the transdermal fentanyl
patches to transdermal melatonin patches for relieving postop-
erative pain after single level lumber laminectomy under
Table 1 Ramsay sedation score.
Score Observation
1 Anxious, agitated or restless
2 Cooperative, oriented and tranquil
3 Responsive to commands
4 Asleep, but with brisk response to light glabellar tap or
loud auditory stimulus
5 Asleep, sluggish response to glabellar tap or auditory
stimulus
6 Asleep, no response
Comparative study on postoperative pain relief 325general anesthesia to detect a mean difference of total anal-
gesic (pethidine) consumption. And our secondary goal was
to compare the effects of the transdermal fentanyl patches to
transdermal melatonin patches on prolongation of first anal-
gesic requirement time, pain score, sedation score, stress
response, patient satisfactory score, surgeon satisfactory score,
postoperative monitoring of heart rate, mean arterial blood
pressure, arterial SpO2 and side effects (e.g. nausea, vomiting,
pruritis, respiratory depression and hemodynamic instability).
2. Methods
This study was designed to be a randomized, placebo-
controlled, double-blind parallel study in which the patients,
investigators, anesthesiologists and the surgeons were blinded
to the given treatment. This study was conducted in Ain-
Shams University Hospitals, from March 2013 to April 2015
on 75 patients aged between 18 and 50 years of both sexes of
ASA physical status I and II of 70–90 kg body weight and
height 160–180 cm undergoing elective single level lumber
laminectomy under general anesthesia. The study protocol
was approved by the institutional ethical committee and writ-
ten informed consent was obtained from all the patients.
Patients with impaired kidney or liver functions, history of
cardiac or central nervous system disease, history of drug or
alcohol abuse, history of chronic pain or daily intake of anal-
gesics, uncontrolled medical disease (diabetes mellitus and
hypertension), history of intake of non-steroidal anti-
inflammatory drugs or opioids within 24 h before surgery or
allergy to the used medications, coagulation defect, local infec-
tion at the site of application of transdermal patch, patient
refusal or duration of surgery more than 120 min were
excluded from the study.
Patients were randomly divided into 3 groups, C group,
(n= 25) each patient received transdermal placebo patch,
TDF group, (n= 25) each patient received transdermal thera-
peutic system-fentanyl 50 lg/h and TDM group, (n= 25) each
patient received transdermal therapeutic system containing
7 mg of melatonin. Randomization was done using
computer-generated number table of random numbers in a
1:1 ratio and conducted using sequentially numbered, opaque
and sealed envelope (SNOSE). All patches were placed 2 h pre-
operatively and were applied to the skin in the subclavicular
area and the area was not shaved to maintain the integrity
of the skin to maintain normal absorption (if necessary hair
was only clipped from the patch site prior to application).
The patch was removed 12 h postoperatively. In this study
we used identical placebo patches assembled by the hospital
pharmacy, and we used fentanyl patches [Durogesic
D-Trans (matrix) from Janssen-Cilag] with delivery rate of
50 lg/h patch and we used melatonin sleep patch from Respro
LabsTM containing 7 mg of melatonin. Active patches contain-
ing fentanyl or melatonin were indistinguishable from placebo
patches, covered with adhesive plaster to confirm fixation and
to blind the anesthetists and observers for the type of the used
patches. The study drugs were prepared by the anesthesia res-
ident not involved in any other part of the study.
Before any patch placement a preoperative visit was done
to all patients to assess patient fitness for operation, to allevi-
ate anxiety, to inform them about transdermal patches (its effi-
cacy in the treatment of postoperative pain, its possible sideeffects and method of application) and to make them familiar-
ized with 10 cm marked visual analog scale (VAS) for postop-
erative assessment of pain, where 0 cm defines no pain and
10 cm defines the maximum intolerable pain. The patients were
also assured that they would receive intramuscular injection
(IM) of pethidine 0.5 mg/kg once they start to first experience
pain postoperatively (Patients with VAS > 3). Time to the first
request for analgesic and the total pethidine consumption were
recorded 12 h postoperatively.
The general anesthesia technique was standardized for all
the patients as well as monitored including 5 lead ECG, non-
invasive blood pressure (NIBP) monitor, pulse oximetry and
capnography after intubation using Datascope monitors. Neu-
romuscular function was also monitored using a peripheral
nerve stimulator. After establishing an intravenous (IV) line,
induction of general anesthesia with fentanyl (2 lg/kg) and
sleeping dose of propofol followed by rocuronium (0.6 mg/
kg) to facilitate orotracheal intubation was done. Anesthesia
was maintained using sevoflurane in oxygen and air. Granise-
tron (1 mg IV) was given as a prophylactic antiemetic. At the
end of the surgery, the residual neuromuscular paralysis was
antagonized with neostigmine (0.05 mg/kg) and atropine
(0.01 mg/kg). After satisfactory recovery, patients were extu-
bated and transferred to the post-anesthesia care unit (PACU)
where they were monitored with ECG, NIBP and pulse
oximetry.
Assessment of postoperative pain, sedation, hemodynamic
variables such as heart rate (HR) and mean arterial pressure
(MAP), postoperative monitoring of arterial SpO2 and side
effects (e.g. nausea, vomiting, pruritis, respiratory depression
and hemodynamic instability) were done 30 min, 1, 2, 6 and
12 h postoperatively.
Postoperative pain was evaluated based on visual analog
scale, first time to ask for rescue analgesia and total pethidine
requirements in 12 h (mg) postoperatively were also recorded.
Assessment of sedation was according to sedation score (Ram-
say sedation score) [28] (see Table 1).
Hypotension was considered if there was 20% decrease
below the baseline for mean arterial blood pressure, and it
was treated with intravenous ephedrine (3–6 mg IV bolus).
Bradycardia (heart rate <55 beats/min) was treated with intra-
venous atropine (0.6–1 mg). If there was a decrease in arterial
SpO2 (<90%), it was treated with oxygen through a transpar-
ent face mask. Severe nausea or vomiting was treated with dex-
amethasone 5 mg and severe pruritus was treated with
clemastine (Tavegyl) 2 mg/ampoule i.v. as required. If any
of the patients developed respiratory depression, the transder-
mal patch was removed and intermittent doses of naloxone
40 mg i.v. were administered.
Likert scale: 
1                          2               3          4               5                       6             7  
Extremely dissatisfied   Dissatisfied   Somewhat dissatisfied   Undecided         Somewhat satisfied       Satisfied   Extremely satisfied 
Figure 1 A 7-point Likert-like verbal rating scale for assessment of patients’ and surgeons‘ satisfaction.
Table 2 Intraoperative bleeding score classification.
Score Descriptions
0 No bleeding
I Slight bleeding, no suctioning of blood required
II Slight bleeding, occasional required suctioning. Surgical
field not threatened
III Slight bleeding, frequent suctioning required. Bleeding
threatens surgical field a few seconds after suction is
removed
IV Moderate bleeding, frequent suctioning required. Bleeding
threatens surgical field directly after suction is removed
V Severe bleeding, constant suctioning required. Bleeding rate
is faster than its removal by suctioning as surgical field is
severely threatened and surgery becomes impossible
7 patients 
excluded
78 patients 
were 
randomized
25 patients in 
groupC 26 patients in 
TDM group
All 
completed 
the study
25 patients 
completed 
the study
1 Dropout
27 patients in 
TDF group  
85 patients were assessed for 
eligibility
Patient refusal 
(4)
Chronic 
analgesic 
consumption (3)
2 Dropouts
25 patients 
completed 
the study
Figure 2 Flowchart of patients (study design).
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answer the question, ‘How would you rate your experience
after the surgery?’ using a 7-point Likert verbal rating scale
(Fig. 1) [29]. Surgeons were also asked to rate their satisfaction
with operative conditions, using the 7-point Likert verbal rat-
ing scale at the end of surgery, acceptable satisfaction score of
both the patient and surgeon being 5–7. Intraoperative bleed-
ing was assessed by bleeding scale (0–5) (Table 2) [30], accept-
able bleeding score being 0–2.
Hormonal stress response was assessed through recording
plasma cortisol (micrograms/dl) 2 h postoperatively. Serum
cortisol was measured by a Fluorescence Polarization
Immunoassay (FPIA) Technology by the Abbott AXSYM sys-
tem with the following reference ranges (morning serum corti-
sol 4.2–38.4 lg/dl and evening serum cortisol 1.7–16.6 lg/dl).
2.1. Analysis of data
Using PASS 13 for sample size calculation, in a one-way
ANOVA study it was calculated that a sample size of 22
patients per group will achieve 80% power to detect a mean
difference of 50 mg in total Pethidine consumption with a
SD of 25 between the three groups using an F test with a
0.05 significance level. 25 patients per group were intended
to be included to replace any dropouts.
Data were analyzed using SPSS 18.0 for Windows (SPSS,
Chicago, IL, USA). Analysis of variance was used to compare
quantitative parametric data with Tukey’s test as a post hoc
test. Kruskal–Wallis test was used for quantitative nonpara-
metric data. Chi square test was used for comparison of qual-
itative data. Continuous parametric data were presented as
mean ± SD, non-parametric data as median (IQR) and cate-
gorical data as number of patients. P-values of <0.05 were
considered statistically significant.
3. Results
A total of 85 patients were assessed for eligibility from March
2013 to April 2015 (Fig. 2), out of which 78 patients receivedstudy medication after randomization, 75 patients completed
the study (25 patients for each group) and their data were
included in the final analysis (Fig. 2). Seven patients were
not included in this study on account of patient’s refusal (4
patients) and history of chronic analgesic consumption (3
patients). Three patients were considered as dropouts after ini-
tial randomization and were therefore not subjected to further
statistical analysis (three patients needed re-exploration on
account of the postoperative bleed).
Results of the current study did not show significant differ-
ence in the demographic data of the groups of patients regard-
ing age, sex (male to female ratio), body weight, height, ASA
physical status and the length of surgery in minutes as shown
in Table 3.
No significant differences in HR between the three groups
were recorded at any time. There were lower recorded values
in the mean heart rate in the TDF and the TDM groups com-
pared to C group, 30 min, 1 h, 2 h and 6 h postoperatively and
this was not significant. There was a decrease in the mean heart
rate in the TDF group compared to the C and the TDM
groups, 12 h postoperatively and this was not significant as
shown in Fig. 3.
There was a significant decrease in the mean arterial blood
pressure in the TDM group compared to the C and the TDF
groups, 30 min, 1 h, 2 h and 6 h postoperatively as shown in
Fig. 4.
No significant changes were noted in the SpO2 between the
studied groups throughout the study period (P> 0.05).
The sedation score was significantly higher in TDM group
compared to the C and the TDF groups, 30 min, 1, 2, and 6 h
postoperatively as shown in Fig. 5.
Table 3 The demographic data.
Variables C group (n= 25) TDF group (n= 25) TDM group (n= 25) p-value
Age (yr.) 43.56 ± 5.7 42.6 ± 4.62 44.56 ± 3.4 0.83
Sex (M/F) 15/10 14/11 13/12 0.21
Weight (kg) 77.18 ± 4.2 76.32 ± 5.9 78.4 ± 3.1 0.57
Height (cm) 166.56 ± 5. 4 170.71 ± 4 168.6 ± 5.2 0.2
ASA (I/II) 11/14 9/16 7/18 0.85
Duration of anesthesia (min) 112.5 ± 6.5 112.8 ± 6.8 111.7 ± 5.2 0.51
Data are presented as mean ± SD. ASA: American Society of Anesthesiologists.
P> 0.05 was considered statistically non-significant between the 3 groups.
Lines are mean heart rate and error bars are SD. 
65
70
75
80
85
90
30m 1h 2h 6h 12h
be
at
/m
in
Heart Rate
group C group TDF group TDM
Figure 3 The heart rate changes (beats/min). Lines are mean
heart rate and error bars are SD.
* denotes signiﬁcant diﬀerence.
Lines are mean MABP and error bars are SD. 
* *
* *
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group C group TDF group TDM
Figure 4 The mean arterial blood pressure (mmHg).
Comparative study on postoperative pain relief 327The middle black solid line represents the median RSS
score, and the upper and lower margins of the boxes are
IQR and the whiskers are minimum and maximum.
There were significant lower recorded values in visual ana-
log scale in the TDF group and TDM group in comparison
with C group, 30 min, 1, 2 and 6 h postoperatively. Pain score
was lower in the TDF group compared to the C and the TDMgroups, 12 h postoperatively and this was not significant as
shown in Fig. 6.
The middle black solid line represents the median VAS
score, the upper and lower margins of the boxes are IQR
and the whiskers are minimum and maximum.
Regarding side effects in our study, all cases of the 3 groups
were hemodynamically stable, no patient developed hypoxia
and there were no reported intraoperative complications inter-
fering with the course of surgery or interrupting the surgeons.
Two patients in the C group suffered from nausea (p= 0.08).
In the TDF group, nausea and vomiting occurred only in 25%
of cases (n= 6/25) (p= 0.01) in spite of the fact that preoper-
ative granisetron (1 mg IV) was given as a prophylactic antie-
metic and there were no reported cases of erythema,
respiratory depression or pruritus. In the TDM group, two
patients were dizzy (p= 0.08).
There was significant difference postoperatively between
the TDF and the TDM groups in comparison with C group
as regards the time for 1st rescue analgesic (minutes) postop,
the total pethidine requirements (mg) 12 h postop, the serum
cortisol (lg/dl) 2 h postop and the patient‘s satisfaction score.
Intraoperative bleeding measured by bleeding scale was statis-
tically significantly less in the TDM group than in the C and
the TDF groups. The surgeon‘s satisfaction score was signifi-
cantly higher in the TDM group compared to the C and the
TDF groups as shown in Table 4.
4. Discussion
In the present study, there was an overall significant reduction
in the VAS score in the TDF and TDM groups when com-
pared with the C group in the 1st 6 h postoperatively. Even
in the next 6 h where there was no significant reduction of
the VAS, it was still lower in the TDF group than the C and
TDM groups. This reduction in the VAS score was associated
with significant delay in the postoperative time for 1st rescue
analgesic (minutes), significant reduction in the postoperative
total pethidine requirements (mg) 12 h postoperatively, signif-
icant reduction in the 2 h postoperative serum cortisol (lg/dl)
and the significant increase in the postoperative patient‘s satis-
faction score as compared with the group C.
Also, this study revealed that the sedation score was signif-
icantly higher in the TDM group compared to the C and the
TDF groups, 30 min, 1, 2, and 6 h postoperatively.
These results are in agreement with the findings of
Radwan et al. (2010) who reported that pre-emptive oral dose
of 6 mg of melatonin reduced the pain scores and pethidine
Figure 5 Sedation score (Ramsay sedation score).
Figure 6 Visual analog scale (VAS).
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Table 4 Postoperative data.
Postoperative data C group (n= 25) TDF group (n= 25) TDM group (n= 25) p-value
Time for 1st rescue analgesic (minutes) postop. 29 .8 ± 2.71y 231.5 ± 5. 81 212.5 ± 3.3 <0.001*
Total pethidine requirements (mg) 12 h postop. 120.8 ± 7.54y 56.32 ± 6.8 60.92 ± 6.4 <0.001*
Serum cortisol 2 h postop. (lg/dl). 31.36 ± 4.64y 21.34 ± 3.3 21.2 ± 3.9 <0.001*
Patient‘s satisfaction score 2 (2–2.5)y 6 (5–6) 6 (5–6) <0.001*
Intraoperative bleeding (0–2) 15(60%) 17(68%) 20(80%) <0.001*
Surgeon‘s satisfaction score 4 (4–5) 4 (4–5) 7 (6–7) <0.001*
Data are presented as mean (SD) or median (interquartile range). * Denotes significant difference.
* P< 0.001 is considered statistically significant between the 3 groups.
y P< 0.001 was considered statistically significant between groups II and III and group I.
 P< 0.001 was considered statistically significant between groups I and II and group III.
Comparative study on postoperative pain relief 329requirements in the first postoperative 24 h in patients under-
going abdominal surgery [31].
Borazaa et al. (2010) also reported that preoperative oral
melatonin 6 mg, the night before and 1 h before surgery,
decreased pain scores and tramadol consumption and
enhanced sleep quality and sedation scores during the postop-
erative period in patients undergoing elective prostatectomy
[32].
These results were consistent with Caumo et al. (2010) who
found that 5 mg oral melatonin, the night before and 1 h
before surgery in patients undergoing abdominal hysterec-
tomy, decreased pain and anxiety during the first 24 h after
surgery [33].
These results are in agreement with the findings of Sevarino
et al. (1992), who compared TDF in two different delivery
rates 25 lg/h and 50 lg/h with placebo for postoperative anal-
gesia after abdominal gynecologic surgery (the patches were
applied one hour before surgery and removed after 72 h) and
found that there was only a significant reduction in the rescue
analgesia in the TDF group with a delivery rate of 50 lg/h [13].
Our results were consistent with the findings of Kilbride
et al. (1994), who compared TDF with delivery rate of
50 lg/h applied six hours before surgery and removed after
72 h with placebo for the management of post-
hemorrhoidectomy pain and found that there was significant
reduction in the pain intensity and rescue analgesia in the
TDF group when compared with the placebo group [34].
These results were partially consistent with the findings of
Sandler et al. (1994), who compared TDF in two different
delivery rates 50 lg/h and 75 lg/h with placebo for postopera-
tive analgesia after abdominal hysterectomy (the patch was
applied two hours before surgery and removed after 72 h)
and found that there was significant reduction in the pain
intensity and rescue analgesia in the TDF group with delivery
rate of 75 lg/h when compared with the placebo group while
in the TDF group with delivery rate of 50 lg/h there was only
a significant reduction in rescue analgesic consumption when
compared with the placebo group [35].
Our results were supported with the findings of Siafaka
et al. (2004), who studied pharmacokinetic profile and efficacy
of a transdermal fentanyl delivery system 50 lg/h for Acute
Postoperative Pain after Intra-abdominal Gynecologic Surgery
for Cancer and found that Transdermal fentanyl provided
effective analgesia for acute postoperative pain and the VAS
pain scores were consistently better in the fentanyl group com-
pared with the placebo group; a better indication of the effi-cacy of fentanyl was the significant 50–65% reduction in the
requirement for bupivacaine among these patients compared
with the placebo group (pain control was supplemented with
a nonopioid drug, bupivacaine 0.125–0.25%, administered
through an epidural catheter via patient-controlled epidural
analgesia) [9].
These results are in agreement with the findings of Minville
et al. (2008), who compared the preoperative transdermal fen-
tanyl patch (TFP) 50 lg/h applied approximately 10 h before
induction of general anesthesia for the postoperative pain
management of patients undergoing primary total hip arthro-
plasty with patient-controlled analgesia (PCA) and found that
Preoperative TFP application decreases pain scores and mor-
phine consumption in the postanesthesia care unit (PACU)
[36].
Our results were supported with the findings of Lauretti
et al. (2009), who reported that TDF 25 lg/h placed 10 h pre-
operatively and removed 24 h later combined with IV ketopro-
fen was effective in controlling postoperative pain after
posterior laminectomy [37].
These results are in agreement with the findings of Barrera
et al. (2009), who concluded that transdermal fentanyl pro-
vided effective postoperative analgesia and reduced analgesic
consumption in patients undergoing dorsal and lumbar spine
arthrodesis [38].
Our results were supported with the findings of Amr et al.
(2012) who found that there was significant reduction in the
VAS scores and rescue analgesia in the TDF group with a
delivery rate of 50 lg/h when compared with the placebo
group during transdermal administration of fentanyl 50 lg/h
10 h preoperatively for postoperative pain relief after major
abdominal surgery. Sedation occurred only in the 1st 8 h post-
operatively and it was only in the form of drowsiness that was
resolved spontaneously [39].
These results were supported by the study of Ismail and
Mowafi (2009) who concluded that oral melatonin premedica-
tion (10 mg tablet) for patients undergoing cataract surgery
under topical anesthesia provided anxiolytic effects, enhanced
analgesia and decreased IOP resulting in good operating con-
ditions (22).
These results were partially consistent with Khezri and
Merate (2013) who reported that sublingual melatonin 3 mg
premedication (60 min before surgery) for patients undergoing
cataract surgery under topical anesthesia reduced the anxiety
scores in patients and they could not demonstrate that mela-
tonin has a decreasing effect on pain scores [40].
330 I.M. Esmat, D.Y. KassimThe significant increase in the postoperative patient’s satis-
faction score in TDM group as compared with group C could
be a consequence of melatonin’s effects on pain and anxiety
which enhance sleep wake cycle disruption in stressful situa-
tions such as surgeries, providing better recovery quality [32].
Clinical trials on the effect of melatonin on delirium in hip
fracture patients are going on. Melatonin has been used suc-
cessfully to treat and prevent post-operative delirium [40].
No significant differences in HR between the three groups
were recorded at any time. There was a significant decrease
in the mean arterial blood pressure in the TDM group com-
pared to the C and the TDF groups, 30 min, 1 h, 2 h and 6 h
postoperatively.
These results were supported by the study of Ismail and
Mowafi (2009) who found that the mean arterial pressure
was decreased after melatonin pre-medication and extended
to the early post-operative period. This mild hypotensive effect
of melatonin may be beneficial in elderly patients, particularly
those at cardiovascular risk [22].
Previous studies showed that melatonin could decrease
MAP in healthy women [41] and men [42]. The mechanism
of action of melatonin on circulation is complex and unclear.
Melatonin may bind to specific melatonin receptors in the
blood vessels, interfering with the vascular response to cate-
cholamine [43]. Furthermore, melatonin may interfere with
the peripheral and central autonomic system, causing a reduc-
tion in adrenergic outflow and catecholamines levels [44]. In
addition, it may induce relaxation of the smooth muscle of
the arterial walls via increasing nitric oxide availability [45,46].
Intraoperative bleeding was significantly less in TDM
group as compared to C and TDF groups. Intraoperative
hypotension effectively decreases surgical blood loss and
improves surgical field exposure which is essential for spinal
surgeries. This result explained significant increase in the sur-
geon‘s satisfaction score in the TDM group compared to the
C and the TDF groups.
As regards the TDF, these results are in agreement with the
findings of Amr et al. (2012) who reported that there were no
statistically significant differences between the TDF and con-
trol (C) groups in the hemodynamic parameters [systolic blood
pressure (SBP), diastolic blood pressure (DBP) and heart rate
(HR)] throughout the period of the study [39].
As regards side effects in our study, all cases of the 3 groups
were hemodynamically stable, no patient developed hypoxia
and there were no reported intraoperative complications inter-
fering with the course of surgery or interrupting the surgeons.
Two patients in the C group suffered from nausea (p= 0.08).
In the TDF group, nausea and vomiting occurred only in 25%
of cases (n= 6/25) (p= 0.01) in spite of the fact that preoper-
ative granisetron (1 mg IV) was given as a prophylactic antie-
metic and there were no reported cases of erythema,
respiratory depression or pruritus. In the TDM group, two
patients were dizzy (p= 0.08).
These results are in agreement with the findings of Amr
et al. (2012) who reported that nausea and vomiting occurred
only in 32% of cases (16/50 patients) during transdermal
administration of fentanyl 50 lg/h 10 h preoperatively for
postoperative pain relief after major abdominal surgery [39].
In the TDF group with delivery rate of 75 lg/h the inci-
dences of respiratory depression, sedation and nausea/vomit-
ing were 11%, 22% and 83% respectively [47]. Another
study showed that, the incidence of respiratory depressionwas higher in the TDF group with delivery rate of 75 lg/h
(15%) than in the TDF group with delivery rate of 50 lg/h
[35]. The results of our study were partially consistent with
Minville et al. (2008) who reported that in the TDF group
(15 patients) with delivery rate of 50 lg/h, there were no
reported cases of sedation, respiratory depression or erythema;
pruritus occurred in one patient and nausea/vomiting occurred
in 7 patients; and the only prominent adverse event was the
occurrence of local erythema in 30% of patients received trans-
dermal fentanyl [36].
Regarding adverse effects in patients who received TDM,
patients were more sedated (P< 0.05) and two patients were
dizzy (p= 0.08). These results were nearly similar to the
results proved by Ismail and Mowafi (2009) who found that
one patient in their melatonin group (n= 20) complained of
dizziness [22].5. Limitations of the study
Our study presented several limitations. First, the results did
not allow for an evaluation of the effectiveness of TDF or
TDM in all types of surgery. The second limitation was the
small sample size preventing achievement safety conclusions.
The third limitation of our study is that we did not measure
fentanyl and melatonin plasma levels so the interaction
between both agents and endogenous melatonin could not be
assessed.6. Conclusion
Transdermal administration of fentanyl 50 lg/h or transder-
mal therapeutic system containing 7 mg of melatonin 2 h pre-
operatively was an effective, simple, noninvasive, and
convenient technique and a safe adjuvant for acute pain after
lumber laminectomy. TDF and TDM allowed delivery of a
potent analgesic agent providing a stable serum concentration
for an extended period of time with acceptable minimal side
effects.7. Recommendations
The use of the TDF or TDM patches as a component of a mul-
timodal analgesic system (i.e. in conjunction with regional
blocks, a non-steroidal anti-inflammatory drug (NSAID), an
acetaminophen or an a-agonist) may provide an effective post-
operative analgesic regimen.
Clinical trial registration: ClinicalTrials.gov Identifier:
NCT02726126Conflict of interest
None.References
[1] Melzack R. Psychological aspects of pain: implications for
neural blockade. In: Cousins MJ, Bridenbaugh PO, editors.
Neural blockade in clinical anesthesia and management of
pain. Philadelphia: J.B. Lippincott; 1989. p. 845–60.
Comparative study on postoperative pain relief 331[2] Desborough JM. The stress response to trauma and surgery. Br
J Anesth 2000;85:109–17.
[3] Carli F, Mayo N, Klubien K, et al. Epidural analgesia enhances
functional exercise capacity and health-related quality of life
after colonic surgery: results of a randomized trial.
Anesthesiology 2002;97:540.
[4] Kissin I. Preemptive analgesia. Anesthesiology 2000;93:1138–43.
[5] McCaffery M, Ferrell B. Nurses’ knowledge of pain assessment
and management: how much progress have we made? J Pain
Symptom Manage 1997;14(3):175–88.
[6] Ku¨cu¨kakin B, Lykkesfeldt J, Nielsen HJ, Reiter RJ, Rosenberg
J, Go¨genur I. Utility of melatonin to treat surgical stress after
major vascular surgery–a safety study. J Pineal Res
2008;44:426–31.
[7] Berner B, John VA. Pharmacokinetic characterization of
transdermal delivery systems. Clin Pharmacokinet
1994;26:121–34.
[8] Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation
through human skin: theory and in vitro experimental
measurement. Am Inst Chem Eng J 1975;21:985–96.
[9] Siafaka I, Rellia P, Argyra E, Iakovidou N, Sykiotis C,
Vadalouka A. Pharmacokinetic profile and efficacy of a
fentanyl transdermal delivery system for acute postoperative
pain after intra-abdominal gynecologic surgery for cancer. Pain
Practice 2004;4(2):98–104.
[10] Muijsers RBR, Wagstaff AJ. Transdermal fentanyl. An updated
review of its pharmacological properties and therapeutic efficacy
in chronic cancer pain control. Drugs 2001;61:2289–307.
[11] McCartney CJ, Sinha A, Katz J. A qualitative systematic review
of the role of N-methyl-D-aspartate receptor antagonists in
preventive analgesia. Anesth Analg 2004;98:1385–400.
[12] Plezia PM, Kramer TH, Linford J, Hameroff SR. Transdermal
fentanyl: pharmacokinetics and preliminary clinical evaluation.
Pharmacotherapy 1989;9:2–9.
[13] Sevarino FB, Naulty JS, Sinatra R, et al. Transdermal fentanyl
for postoperative pain management in patients recovering from
abdominal gynecologic surgery. Anesthesiology 1992;77
(3):463–6.
[14] Bromage PR, Shibata HR, Willoughby HW. Influence of
prolonged epidural blockade on blood sugar and cortisol
responses to operations upon the upper part of the abdomen
and thorax. Surg Gynaecol Obstetr 1971;21:330–5.
[15] Donner B, Zenz M, Tryba M, et al. Fentanyl TTS zur
postoperativen Schmerztherapie. A neue Alternative?
Anesthetist 1993;42(5):309–15.
[16] Arendt J. In melatonin and the mammalian pineal
gland. London: Chapman & Hall; 1995, p. 42, 207.
[17] Barrenetxe J, Delagrange P, Martinez JA. J Physiol Biochem
2004;60:61.
[18] Waldhauser F, Waldhauser M, Lieberman HR, Deng MH,
Lynch HJ, Wurtman R. J Neuroendocrinol 1984;39:307–13.
[19] Lee B, Parrott K, Ayres J, Sack R. Res Commun Mol Path
Pharmacol 1994;85(3):337–46.
[20] Ku¨cu¨kakin B. Modification of surgical stress response by
perioperative melatonin administration. Dan Med Bull 2010;57
(5):B4144.
[21] Zahn PK, Lansmann T, Berger E, Speckmann E, Musshoff U.
Gene expression and functional characterization of melatonin
receptors in the spinal cord of the rat: implications for pain
modulation. J Pineal Res 2003;35:24–31.
[22] Ismail SA, Mowafi HA. Melatonin provides anxiolysis,
enhances analgesia, decreases intraocular pressure, and
promotes better operating conditions during cataract surgery
under topical anesthesia. Anesth Analg 2009;108:1146–51.
[23] Yu CX, Zhu CB, Xu SF, Cao XD, Wu GC. Selective MT2
melatonin receptor antagonist blocks melatonininduced
antinociception in rats. Neurosci Lett 2000;282:161–4.[24] Benyahia N-M, Breebaart MB, Sermeus L, Vercauteren M.
Regional analgesia techniques for spine surgery: a review with
special reference to scoliosis fusion. J Spine 2015;4:208. http://
dx.doi.org/10.4172/2165-7939.1000208.
[25] Rahimzadeh P, Faiz SHR, Alimian M, Mohammadian Erdi A.
Remifentanil versus dexmedtomidine for posterior spinal fusion
surgery. Med J Islam Repub Iran 2015;29:215 [6 June].
[26] Rutberg H, Hakanson E, Anderberg L, Jorfeldt L, Martensson
J, Schildt B. Effects of the extradural administration of
morphine, or bupivacaine, on the endocrine response to upper
abdominal surgery. Br J Anesth 1984;56:233–7.
[27] Hjortso N-C, Christensen NJ, Andersen T, Kehlet H. Effects of
the extradural administration of local anesthetic agents and
morphine on the urinary excretion of cortisol, catecholamines,
and nitrogen following abdominal surgery. Br J Anesth
1985;57:400–6.
[28] Riker RR, Picard JT, Fraser GL. Prospective evaluation of the
sedation–agitation scale for adult critically ill patients. Crit Care
Med 1999;27:1325–9.
[29] Streiner DL, Norman GR. Scaling responses. In: Streiner DL,
Norman GR, editors. Health measurement scales: a practical
guide to their development and use. Oxford: Oxford University
Press; 1995. p. 28–53.
[30] Rathjen T, Bockmuhl U, Greim CA. Modern anesthesiologic
concepts supporting paranasal sinus surgery.
Laryngorhinootologie 2006;85:20–3.
[31] Radwan K, Youssef M, El-Tawdy A, Zeidan M, Kamal N.
Melatonin versus Gabapentin. A comparative study of
preemptive medications. Internet J Anesthesiol 2010;23(1)
[DOI:10.5580/265See more at: http://www.ispub.com/journal/
theinternetjournalofanesthesiology/volume-23-number-1/
melatoninversusgabapentinacomparativestudyas
preemptivemedications.html#sthash.tGPya1vY.dpuf].
[32] Borazaa H, Tuncer S, Yalcin N, Erol A, Otelcioglu S. Effects of
preoperative oral melatonin premedication on postoperative
analgesia, sleep quality and sedation in patients undergoing
elective prostatectomy: a randomized clinical trial. J Aesth
2010;24:155–60.
[33] Caumo W, Torres F, Moreira Jr NL, Auzani JA, Monteiro CA,
Londero G, et al. The clinical impact of pre-operative melatonin
on post-operative outcomes in patients undergoing abdominal
hysterectomy. Anesth Analg 2007;105:1263–71.
[34] Kilbride M, Morse M, Senagore A. Transdermal fentanyl
improves management of postoperative hemorrhoidectomy
pain. Dis Colon Rectum 1994;37(11):1070–2.
[35] Sandler AN, Baxter AD, Katz J, et al. A double-blind, placebo-
controlled trial of transdermal fentanyl after abdominal
hysterectomy. Analgesic, respiratory, and pharmacokinetic
effects. Anesthesiology 1994;81:1169–80.
[36] Minville V, Lubrano V, Bounes V, Pianezza A, Rabinowitz A,
Gris C, et al. Postoperative analgesia after total hip
arthroplasty: patient-controlled analgesia versus transdermal
fentanyl patch. J Clin Anesth 2008;20:280–3.
[37] Lauretti GR, Mattos AL, Almeida R, Lima ICPR, Resende CS.
Efficacy of fentanyl transdermal delivery system for acute
postoperative pain after posterior laminectomy. Post Sess/
Euro J Pain 2009;13:S55–S285.
[38] Barrera E, Fernandez-Galinski S, Ferrer MD, Escolano F, Puig
M. Postoperative analgesia induced by transdermal fentanyl in
dorsal and lumbar spine arthrodesis. Post Sess/Euro J Pain
2009;13:S255–85.
[39] Amr Samy A, Mostafa Mostafa G, Mostafa Mohamed AM.
Efficacy and safety of transdermal fentanyl patches on
postoperative pain relief after major abdominal surgery. J Am
Sci 2012;8(6):417–24.
[40] Khezri MB, Merate H. The effects of melatonin on anxiety and
pain scores of patients, intraocular pressure, and operating
332 I.M. Esmat, D.Y. Kassimconditions during cataract surgery under topical anesthesia. Ind
J Ophthalmol 2013;61:319–24.
[41] De Jonghe A, Van Munster BC, van Oosten HE, Goslings JC,
Kloen P, van Rees C, et al. The effects of melatonin versus
placebo on delirium in hip fracture patients: Study protocol of a
randomized, placebocontrolled, double blind trial. BMC Geriatr
2011;11:34.
[42] Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GB.
Influences of melatonin administration on the circulation of
women. Am J Physiol 1998;274:R335–8.
[43] Arangino S, Cagnacci A, Angiolucci M, Vacca AM, Longu G,
Volpe A, et al. Effects of melatonin on vascular reactivity,
catecholamine levels, and blood pressure in healthy men. Am J
Cardiol 1999;83:1417–9.
[44] Sewerynek E. Melatonin and the cardiovascular system. Neuro
Endocrinol Lett 2002;23(suppl 1):79–83.[45] Buijs RM, La Fleur SE, Wortel J, Van Heyningen C, Zuiddam
L, Mettenleiter TC, et al. The suprachiasmatic nucleus balances
sympathetic and parasympathetic output to peripheral organs
through separate preautonomic neurons. J Comp Neurol
2003;464:36–48.
[46] Anwar MM, Meki AR, Rahma HH. Inhibitory effects of
melatonin on vascular reactivity: possible role of vasoactive
mediators. Comp Biochem Physiol C Toxicol Pharmacol
2001;130:357–67.
[47] Sevarino FB, Paige D, Sinatra RS, et al. Postoperative analgesia
with parenteral opioids: does continuous delivery utilizing a
transdermal opioid preparation affect analgesic efficacy or
patient safety? J Clin Anesth 1997;9(3):173–8.
